MicrodosingCreativity

Microdosing psychedelics - Does it have an impact on emodiversity?

This observational naturalistic study (n=18) on microdosing found that it led to a decrease in positive and overall emotional diversity (emodiversity). Participants experienced more awe, wonder, or amazement and ashamed, humiliated, or disgraced emotions during microdosing days and fewer joyful, glad, or happy emotions.

Authors

  • Pop, I.
  • Dinkelacker, J.

Published

Journal of Psychedelic Studies
individual Study

Abstract

Background and aims Previous research has proposed that microdosing, i.e., the repeated use of sub-threshold doses of serotonergic hallucinogens, has an impact on mood by increasing emotional awareness. We propose that increased emotional awareness could translate into higher emodiversity, a balanced experience of emotions in which emotions are experienced with more similarity in intensity and duration. We examine the effect of microdosing, the day after, as well as the cumulative effect of microdosing on overall, positive and negative emodiversity.

Methods

We use data collected over a period of 28 days sampled between February to June 2020 from 18 users that already had an active practice of microdosing at the start of the data collection. We assessed emotional states using ESM methods, i.e., signal-contingent sampling with triggers sent 5 times a day. The working dataset has a number of 224 observations days. We used mixed effects models to test our hypotheses.

Results

When taking into account the level of average affect, we found that during microdosing days positive and overall emodiversity were significantly lower. No evidence was found for a mediating role of the level of average affect. Higher cumulative instances of microdosing were not related to any of the emodiversity indexes. Participants experienced more “awe, wonder, or amazement”, “ashamed, humiliated, or disgraced” as well as less “joyful, glad, or happy” emotions during microdosing days.

Conclusion

A microdosing practice may increase the centrality of certain emotions on microdosing days, resulting in a decrease in emotional diversity.

Available with Blossom Pro

Research Summary of 'Microdosing psychedelics - Does it have an impact on emodiversity?'

Introduction

Microdosing refers to the repeated ingestion of sub-perceptual doses of serotonergic psychedelics (for example LSD or psilocybin) with the aim of improving mood, wellbeing or cognitive function. Earlier qualitative and observational work has largely emphasised beneficial effects on mood, creativity and functioning, but quantitative and experimental studies report a fragmented and sometimes contradictory picture. Pop and colleagues argue that much prior research mixes therapeutic and enhancement aims and varies widely in design, and therefore propose emodiversity — a measure of the richness and evenness of experienced emotions — as a targeted outcome that may capture changes in emotional awareness associated with microdosing. This study sets out to test whether microdosing produces acute effects (on the day of ingestion and the day after) and cumulative effects (across repeated microdosing occasions) on overall, positive and negative emodiversity. Using repeated within-person measurement over 28 days, the researchers aim to distinguish day-level (acute) from cumulative effects and to exploit intensive sampling to better control for confounding factors. The study therefore examines whether emodiversity is higher on microdosing days and whether it increases with the number of prior microdosing days during the observation period.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

  • Study Type
    individual
  • Journal
  • Topics
  • APA Citation

    Pop, I., & Dinkelacker, J. (2023). Microdosing psychedelics - Does it have an impact on emodiversity?. Journal of Psychedelic Studies, 7(1), 29-35. https://doi.org/10.1556/2054.2022.00208

References (10)

Papers cited by this study that are also in Blossom

Psychedelic microdosing benefits and challenges: an empirical codebook

Anderson, T., Petranker, R., Christopher, A. et al. · Harm Reduction Journal (2019)

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers

Anderson, T., Petranker, R., Rosenbaum, D. et al. · Psychopharmacology (2019)

142 cited
Exploring the relationship between microdosing, personality and emotional insight: A prospective study

Dressler, H. M., Bright, S. J., Polito, V. · Journal of Psychedelic Studies (2021)

42 cited
Motives and side-effects of microdosing with psychedelics among users

Hutten, N. P. W., Mason, N. L., Dolder, P. C. et al. · International Journal of Neuropsychopharmacology (2019)

Powerful substances in tiny amounts An interview study of psychedelic microdosing

Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)

121 cited
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Kaertner, L. S., Steinborn, M. B., Kettner, H. et al. · Scientific Reports (2021)

112 cited
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

Kuypers, K. P. C., Erritzoe, D., Knudsen, G. M. et al. · Journal of Psychopharmacology (2019)

Cited By (2)

Papers in Blossom that reference this study

Microdosing psychedelics has no impact on cognitive function in naturalistic settings

Dinkelacker, J., Pop, I. · Journal of Clinical Psychiatry (2023)

2 cited
Unlocking the self: Can microdosing psychedelics make one feel more authentic?

Pop, I., Dinkelacker, J. · Nordic Studies on Alcohol and Drugs (2023)

5 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Microdosing psychedelics - Does it have an impact... — Research Summary & Context | Blossom